Clinical trials recruiting in Antony, France

Phase breakdown

Conditions recruiting in Antony, France

Recruiting trials in Antony, France

• 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)
  NCT06349512 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• DESTINY Breast Respond HER2-(Ultra)Low Europe
  NCT05945732 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• PRostate Olaparib Real World Evidence Study
  NCT06031805 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
  NCT06207981 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
  NCT02885753 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Antony, France?

5 recruiting trials have at least one study site in Antony, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.